Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy

Heart failure (HF) with preserved left ventricular ejection fraction is a common disease with a poor prognosis and rising prevalence in the community. The current paradigm of treatment includes symptomatic therapy, such as diuretics, and risk factor control and treatment of comorbidities. According...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Mauro, D'Elia, Emilia, Sciatti, Edoardo, Senni, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Patients with HFpEF
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295008/
https://www.ncbi.nlm.nih.gov/pubmed/35865457
http://dx.doi.org/10.15420/cfr.2022.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295008/
https://www.ncbi.nlm.nih.gov/pubmed/35865457
http://dx.doi.org/10.15420/cfr.2022.04

Ejemplares similares